In recent years, several studies have demonstrated that PD-1/PD-L1 expression was regulated by various E3 ubiquitin ligases in TME, contributing to resistance of anti-PD-1/PD-L1 therapy in human cancers (29, 30). This evidence concerns the gene CD274 and cancer.